SecBot SecBot
SECBOTREPLAY Home › Report › NBIX

NBIX · PGR instituted on Spruce patent

NEUROCRINE BIOSCIENCES INC · PTAB-TRIAL filed Nov 9, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

PTAB-TRIAL filed Nov 9, 2026 at 19:00 ET

The PTAB granted institution of post-grant review (PGR2026-00061) on Neurocrine's petition challenging claims of Spruce Biosciences' patent covering methods for treating testicular and ovarian adrenal rest tumors. This is an interlocutory ruling that opens a trial; no claims have been cancelled yet.

  • PTAB instituted PGR2026-00061 on November 10, 2026
  • Patent U.S. 12576084 covers methods for treating testicular and ovarian adrenal rest tumors
  • Neurocrine Biosciences is the petitioner; Spruce Biosciences is the patent owner
  • Institution granted means the Board found it more likely than not that at least one challenged claim is unpatentable

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access